CFID works with strategic partners and supporters to hasten
the discovery of innovative solutions to better understand,
diagnose, prevent, control and treat existing and
emerging infectious diseases that threaten our good health.

Strategic Funds

As the world we live in changes, so do the challenges we face to identify, treat, control and prevent infectious diseases. The issues affecting our health are diverse, complex and many. In addition to supporting the work of Young Investigators through grants, awards and fellowships, the Canadian Foundation for Infectious Diseases has identified several areas of research that require immediate support. You have the option of allowing the Foundation to apply your donation to the areas most in need, or directing your donation to a specific Fund that you believe is worthy of your support.

Infectious Diseases Professional Development Fund

This fund was originally established in 1996 to support efforts to attract, train and retain the best researchers, practioners and educators specializing in infectious disease and medical microbiology. Funds are used to promote education and professional development through special lectureships and professional forums, and to facilitate sharing of global expertise and development of reciprocoal networks through collaborative projects. The CFID State of the Art Clinical Lecture series presented at the AMMI Canada - CACMID Annual Conferences is an example of such an endeavour.

Fellowship and Studentship Awards

CFID offers a number of fellowships and studentship awards as well as the Embil awards based on an annual competition. Funds are urgently needed to attract and support bright young minds into the field through training grants and undergraduate as well as medical student summer research stipends. In addition, annual awards are established to honour trainees for excellence in research (Juan A. Embil Research Award), and faculty for distinction in mentorship (John M. Embil Mentorship Award).

Bill Lowthian Antimicrobial Resistance Research Fund

Antibiotics are our key weapon to fight disease-causing microorganisms. Unfortunately, many microbes have become increasingly resistant to antibiotics such that in some instances (for example, multi-drug resistant tuberculosis), existing antibiotics are no longer effective and surgical treatment becomes the last resort. A two-pronged approach is necessary to overcome this alarming trend: doubling research efforts to discover new drugs, and intensive education of both physicians and the public to curtail inappropriate use or overuse of antibiotics. This fund is dedicated to support research into antimicrobial resistance, the diagnosis, treatment and prevention of infections due to these microorganisms (e.g. Clostridium difficile, MRSA, VRE, etc.), and promotion of antimicrobial stewardship through education and advocacy.

Safe Drinking Water Research Fund

This restricted fund was established by Dr. Michel Bergeron in 1999 for the promotion of studies investigating one of Canada's most valuable resources, water. Notably, one in eight people around the world do not have access to safe drinking water leading to significant global morbidity and mortality. It is intended as seed funding to promote research in this field and protect the safety of drinking water for all Canadians.

Prevention of Hospital-acquired Infections Research Fund

Hospital-acquired infections (also known as nosocomial infections or healthcare-associated infections) are infections acquired while being treated in a healthcare facility for some other condition. These infections are particularly difficult to treat because they tend to be resistant to common antibiotics and spread rapidly in the hospital environment. They cause much human suffering as well as draining precious healthcare dollars. A 2003 Canadian study estimated that 220,000 cases of hospital-acquired infections occur within Canadian hospitals each year, resulting in at least 8,000 deaths annually. CFID has identified this area as a priority research focus in its Strategic Plan for 2011-13. Innovative strategies for detection as well as treatment and prevention of hospital acquired outbreaks caused by Clostridium difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and multidrug-resistant enteric gram-negative bacteria are critically needed.

Other High Priority CFID Research or Outreach Programs

The CFID Board meets monthly to review research priorities. A strategic plan for the upcoming three years has been developed that includes a clear research agenda with funding priorities and allocations, and criteria for application and adjudication. Other priority research areas identified by the current CFID Board include: HIV/AIDS research, sexually transmitted infections and other community-acquired infections, immunization and vaccine development, antimicrobial stewardship, and support for national educational and advocacy activities such as Antibiotic Awareness Week.